Transoral robotic surgery for supraglottic squamous cell carcinoma

Steven M. Olsen, Eric J. Moore, Cody A. Koch, Daniel L. Price, Jan Kasperbauer, Kerry D. Olsen

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Purpose: We present our experience with the use of transoral robotic surgery (TORS) for treatment of supraglottic squamous cell carcinoma. Materials and Methods: We studied all patients who underwent TORS for supraglottic squamous cell carcinoma, with or without adjuvant therapy, from March 2007 through June 2009, who had a minimum of 2 years of follow-up. Primary functional outcomes included dysphonia, tracheostomy dependence, and gastrostomy tube dependence. Disease control and survival were estimated with the Kaplan-Meier method. Results: Of 9 patients in the study group, 7 (78%) had advanced-stage disease. All 9 patients had negative margins after TORS, with no perioperative complications. Regional recurrence and local recurrence developed in 1 patient each. One patient died of disease. At last follow-up, 7 patients (78%) were tracheostomy free, and 7 (78%) were gastrostomy tube free. Conclusions: Transoral robotic surgery is a promising modality for resection of supraglottic squamous cell carcinoma. Transoral robotic surgery achieved functional laryngeal preservation in most patients with no complications.

Original languageEnglish (US)
Pages (from-to)379-384
Number of pages6
JournalAmerican Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume33
Issue number4
DOIs
StatePublished - Jul 1 2012

Fingerprint

Robotics
Squamous Cell Carcinoma
Gastrostomy
Tracheostomy
Dysphonia
Recurrence
Survival
Therapeutics

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Transoral robotic surgery for supraglottic squamous cell carcinoma. / Olsen, Steven M.; Moore, Eric J.; Koch, Cody A.; Price, Daniel L.; Kasperbauer, Jan; Olsen, Kerry D.

In: American Journal of Otolaryngology - Head and Neck Medicine and Surgery, Vol. 33, No. 4, 01.07.2012, p. 379-384.

Research output: Contribution to journalArticle

Olsen, Steven M. ; Moore, Eric J. ; Koch, Cody A. ; Price, Daniel L. ; Kasperbauer, Jan ; Olsen, Kerry D. / Transoral robotic surgery for supraglottic squamous cell carcinoma. In: American Journal of Otolaryngology - Head and Neck Medicine and Surgery. 2012 ; Vol. 33, No. 4. pp. 379-384.
@article{451c13fc5385438b9aa98c22e6fadf84,
title = "Transoral robotic surgery for supraglottic squamous cell carcinoma",
abstract = "Purpose: We present our experience with the use of transoral robotic surgery (TORS) for treatment of supraglottic squamous cell carcinoma. Materials and Methods: We studied all patients who underwent TORS for supraglottic squamous cell carcinoma, with or without adjuvant therapy, from March 2007 through June 2009, who had a minimum of 2 years of follow-up. Primary functional outcomes included dysphonia, tracheostomy dependence, and gastrostomy tube dependence. Disease control and survival were estimated with the Kaplan-Meier method. Results: Of 9 patients in the study group, 7 (78{\%}) had advanced-stage disease. All 9 patients had negative margins after TORS, with no perioperative complications. Regional recurrence and local recurrence developed in 1 patient each. One patient died of disease. At last follow-up, 7 patients (78{\%}) were tracheostomy free, and 7 (78{\%}) were gastrostomy tube free. Conclusions: Transoral robotic surgery is a promising modality for resection of supraglottic squamous cell carcinoma. Transoral robotic surgery achieved functional laryngeal preservation in most patients with no complications.",
author = "Olsen, {Steven M.} and Moore, {Eric J.} and Koch, {Cody A.} and Price, {Daniel L.} and Jan Kasperbauer and Olsen, {Kerry D.}",
year = "2012",
month = "7",
day = "1",
doi = "10.1016/j.amjoto.2011.10.007",
language = "English (US)",
volume = "33",
pages = "379--384",
journal = "American Journal of Otolaryngology - Head and Neck Medicine and Surgery",
issn = "0196-0709",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Transoral robotic surgery for supraglottic squamous cell carcinoma

AU - Olsen, Steven M.

AU - Moore, Eric J.

AU - Koch, Cody A.

AU - Price, Daniel L.

AU - Kasperbauer, Jan

AU - Olsen, Kerry D.

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Purpose: We present our experience with the use of transoral robotic surgery (TORS) for treatment of supraglottic squamous cell carcinoma. Materials and Methods: We studied all patients who underwent TORS for supraglottic squamous cell carcinoma, with or without adjuvant therapy, from March 2007 through June 2009, who had a minimum of 2 years of follow-up. Primary functional outcomes included dysphonia, tracheostomy dependence, and gastrostomy tube dependence. Disease control and survival were estimated with the Kaplan-Meier method. Results: Of 9 patients in the study group, 7 (78%) had advanced-stage disease. All 9 patients had negative margins after TORS, with no perioperative complications. Regional recurrence and local recurrence developed in 1 patient each. One patient died of disease. At last follow-up, 7 patients (78%) were tracheostomy free, and 7 (78%) were gastrostomy tube free. Conclusions: Transoral robotic surgery is a promising modality for resection of supraglottic squamous cell carcinoma. Transoral robotic surgery achieved functional laryngeal preservation in most patients with no complications.

AB - Purpose: We present our experience with the use of transoral robotic surgery (TORS) for treatment of supraglottic squamous cell carcinoma. Materials and Methods: We studied all patients who underwent TORS for supraglottic squamous cell carcinoma, with or without adjuvant therapy, from March 2007 through June 2009, who had a minimum of 2 years of follow-up. Primary functional outcomes included dysphonia, tracheostomy dependence, and gastrostomy tube dependence. Disease control and survival were estimated with the Kaplan-Meier method. Results: Of 9 patients in the study group, 7 (78%) had advanced-stage disease. All 9 patients had negative margins after TORS, with no perioperative complications. Regional recurrence and local recurrence developed in 1 patient each. One patient died of disease. At last follow-up, 7 patients (78%) were tracheostomy free, and 7 (78%) were gastrostomy tube free. Conclusions: Transoral robotic surgery is a promising modality for resection of supraglottic squamous cell carcinoma. Transoral robotic surgery achieved functional laryngeal preservation in most patients with no complications.

UR - http://www.scopus.com/inward/record.url?scp=84863227906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863227906&partnerID=8YFLogxK

U2 - 10.1016/j.amjoto.2011.10.007

DO - 10.1016/j.amjoto.2011.10.007

M3 - Article

C2 - 22133967

AN - SCOPUS:84863227906

VL - 33

SP - 379

EP - 384

JO - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

JF - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

SN - 0196-0709

IS - 4

ER -